U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 135

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr13:103506164
GRCh38:
Chr13:102853814
BIVM-ERCC5, ERCC5K108fs, K562fsXeroderma pigmentosum, group GLikely pathogeniccriteria provided, single submitter
2.
GRCh37:
Chr13:103518244
GRCh38:
Chr13:102865894
BIVM-ERCC5, ERCC5, LOC126861834W1182R, W728RXeroderma pigmentosum, group GUncertain significanceno assertion criteria provided
3.
GRCh37:
Chr13:103506636
GRCh38:
Chr13:102854286
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GLikely pathogenicno assertion criteria provided
4.
GRCh37:
Chr13:103506225
GRCh38:
Chr13:102853875
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr13:103513855
GRCh38:
Chr13:102861505
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, not provided
Pathogenic/Likely pathogenic
(Oct 4, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr13:103514538
GRCh38:
Chr13:102862188
BIVM-ERCC5, ERCC5A347S, A801Snot provided, Xeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3
Uncertain significance
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr13:103519054
GRCh38:
Chr13:102866704
BIVM-ERCC5, ERCC5, LOC126861834D1252Y, D798Ynot providedUncertain significance
(Jun 17, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr13:103528246
GRCh38:
Chr13:102875896
BIVM-ERCC5, ERCC5K1185T, K1639TCerebrooculofacioskeletal syndrome 3, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G,
Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(May 13, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr13:103528130
GRCh38:
Chr13:102875780
BIVM-ERCC5, ERCC5S1146R, S1600RCerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group GUncertain significance
(Jun 23, 2020)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr13:103528113
GRCh38:
Chr13:102875763
BIVM-ERCC5, ERCC5G1141R, G1595RXeroderma pigmentosum, group GUncertain significance
(Feb 2, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr13:103519117
GRCh38:
Chr13:102866767
BIVM-ERCC5, ERCC5, LOC126861834R819W, R1273WXeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G
Uncertain significance
(Feb 9, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr13:103519045
GRCh38:
Chr13:102866695
LOC126861834, BIVM-ERCC5, ERCC5A1249T, A795TXeroderma pigmentosum, group G, not specified, not provided
Uncertain significance
(Nov 6, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr13:103518660
GRCh38:
Chr13:102866310
BIVM-ERCC5, ERCC5, LOC126861834Xeroderma pigmentosum, group GUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
14.
GRCh37:
Chr13:103514542
GRCh38:
Chr13:102862192
ERCC5, BIVM-ERCC5M802R, M348RXeroderma pigmentosum, group GUncertain significance
(Mar 23, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr13:103514529
GRCh38:
Chr13:102862179
BIVM-ERCC5, ERCC5T344A, T798AHereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group GUncertain significance
(Jan 14, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr13:103514431
GRCh38:
Chr13:102862081
BIVM-ERCC5, ERCC5S765C, S311CHereditary cancer-predisposing syndrome, not provided, Inborn genetic diseases,
Xeroderma pigmentosum, group G
Uncertain significance
(Jun 2, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr13:103498471
GRCh38:
Chr13:102846121
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr13:103498425
GRCh38:
Chr13:102846075
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
19.
GRCh37:
Chr13:103528103
GRCh38:
Chr13:102875753
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr13:103527944
GRCh38:
Chr13:102875594
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr13:103518253
GRCh38:
Chr13:102865903
BIVM-ERCC5, ERCC5, LOC126861834I1185F, I731FXeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr13:103518011
GRCh38:
Chr13:102865661
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr13:103515458
GRCh38:
Chr13:102863108
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GUncertain significance
(May 6, 2021)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr13:103510760
GRCh38:
Chr13:102858410
BIVM-ERCC5, ERCC5M676V, M222VHereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group GUncertain significance
(Jul 9, 2021)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr13:103498237
GRCh38:
Chr13:102845887
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr13:103508413
GRCh38:
Chr13:102856063
BIVM-ERCC5, ERCC5E614V, E160VXeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr13:103506135
GRCh38:
Chr13:102853785
BIVM-ERCC5, ERCC5A98V, A552VXeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G
Uncertain significance
(Dec 9, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr13:103515270
GRCh38:
Chr13:102862920
BIVM-ERCC5, ERCC5S1045R, S591RXeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr13:103514997
GRCh38:
Chr13:102862647
BIVM-ERCC5, ERCC5R954W, R500WXeroderma pigmentosum, group G, Inborn genetic diseasesUncertain significance
(Jul 30, 2021)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr13:103528341
GRCh38:
Chr13:102875991
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Mar 30, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr13:103528225
GRCh38:
Chr13:102875875
BIVM-ERCC5, ERCC5R1632H, R1178HXeroderma pigmentosum, group G, Ovarian cancerConflicting interpretations of pathogenicity
(Jan 1, 2022)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr13:103524625
GRCh38:
Chr13:102872275
BIVM-ERCC5, ERCC5R1373Q, R919QXeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
33.
GRCh37:
Chr13:103520533
GRCh38:
Chr13:102868183
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr13:103514631
GRCh38:
Chr13:102862281
BIVM-ERCC5, ERCC5V378I, V832IXeroderma pigmentosum, group GUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr13:103504625
GRCh38:
Chr13:102852275
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr13:103504458
GRCh38:
Chr13:102852108
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GUncertain significance
(Jul 12, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr13:103498692
GRCh38:
Chr13:102846342
BIVM-ERCC5, ERCC5I26VHereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group GLikely benign
(Dec 21, 2020)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr13:103498648
GRCh38:
Chr13:102846298
ERCC5, BIVM-ERCC5E11AXeroderma pigmentosum, group GUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr13:103515286
GRCh38:
Chr13:102862936
BIVM-ERCC5, ERCC5A1050G, A596GXeroderma pigmentosum, group GUncertain significance
(May 28, 2019)
criteria provided, single submitter
40.
GRCh37:
Chr13:103515267
GRCh38:
Chr13:102862917
BIVM-ERCC5, ERCC5V1044I, V590IHereditary cancer-predisposing syndrome, not provided, Cerebrooculofacioskeletal syndrome 3,
Xeroderma pigmentosum, group G
Conflicting interpretations of pathogenicity
(Aug 25, 2022)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr13:103514020-103514021
GRCh38:
Chr13:102861670-102861671
BIVM-ERCC5, ERCC5V281fs, V735fsXeroderma pigmentosum, group GPathogenic
(May 28, 2019)
criteria provided, single submitter
42.
GRCh37:
Chr13:103518692
GRCh38:
Chr13:102866342
BIVM-ERCC5, ERCC5, LOC126861834not provided, Xeroderma pigmentosum, group GConflicting interpretations of pathogenicity
(Sep 1, 2022)
criteria provided, conflicting interpretations
43.
GRCh37:
Chr13:103506136
GRCh38:
Chr13:102853786
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, not providedConflicting interpretations of pathogenicity
(Apr 26, 2018)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr13:103519119
GRCh38:
Chr13:102866769
BIVM-ERCC5, ERCC5, LOC126861834not provided, Xeroderma pigmentosum, group GBenign/Likely benign
(Sep 25, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr13:103518036
GRCh38:
Chr13:102865686
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GBenign
(Sep 25, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr13:103528184
GRCh38:
Chr13:102875834
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GConflicting interpretations of pathogenicity
(May 17, 2022)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr13:103514628
GRCh38:
Chr13:102862278
BIVM-ERCC5, ERCC5A377fs, A831fsXeroderma pigmentosum, group GUncertain significance
(Dec 5, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr13:103527869
GRCh38:
Chr13:102875519
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GBenign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr13:103519015
GRCh38:
Chr13:102866665
BIVM-ERCC5, ERCC5, LOC126861834Q785*, Q1239*Xeroderma pigmentosum, group GLikely pathogenic
(Feb 20, 2017)
criteria provided, single submitter
50.
GRCh37:
Chr13:103514459
GRCh38:
Chr13:102862109
ERCC5, BIVM-ERCC5not provided, Xeroderma pigmentosum, group GBenign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr13:103528342
GRCh38:
Chr13:102875992
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, not providedBenign
(Feb 24, 2019)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr13:103528337
GRCh38:
Chr13:102875987
ERCC5, BIVM-ERCC5Xeroderma pigmentosum, group G, not providedBenign
(Nov 11, 2018)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr13:103528224
GRCh38:
Chr13:102875874
BIVM-ERCC5, ERCC5R1178C, R1632CXeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
54.
GRCh37:
Chr13:103528184
GRCh38:
Chr13:102875834
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GConflicting interpretations of pathogenicity
(Jul 1, 2023)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr13:103528178
GRCh38:
Chr13:102875828
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome, not provided
Conflicting interpretations of pathogenicity
(Dec 1, 2022)
criteria provided, conflicting interpretations
56.
GRCh37:
Chr13:103528120
GRCh38:
Chr13:102875770
BIVM-ERCC5, ERCC5A1143V, A1597Vnot provided, Xeroderma pigmentosum, group GConflicting interpretations of pathogenicity
(Feb 1, 2023)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr13:103528104
GRCh38:
Chr13:102875754
BIVM-ERCC5, ERCC5V1138M, V1592MHereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group GUncertain significance
(Dec 28, 2021)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr13:103527695
GRCh38:
Chr13:102875345
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, not providedConflicting interpretations of pathogenicity
(Jun 13, 2018)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr13:103527643
GRCh38:
Chr13:102875293
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr13:103524713
GRCh38:
Chr13:102872363
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr13:103524687
GRCh38:
Chr13:102872337
BIVM-ERCC5, ERCC5V940M, V1394MXeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, not provided,
Xeroderma pigmentosum, group G, Inborn genetic diseases, Hereditary cancer-predisposing syndrome,
not specified
Conflicting interpretations of pathogenicity
(Sep 1, 2023)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr13:103524647
GRCh38:
Chr13:102872297
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome
Benign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr13:103520529
GRCh38:
Chr13:102868179
BIVM-ERCC5, ERCC5P867L, P1321LCerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group GUncertain significance
(Feb 2, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr13:103520453
GRCh38:
Chr13:102868103
BIVM-ERCC5, ERCC5Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G, not provided
Conflicting interpretations of pathogenicity
(Jan 16, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr13:103518967
GRCh38:
Chr13:102866617
BIVM-ERCC5, ERCC5, LOC126861834Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr13:103518707
GRCh38:
Chr13:102866357
BIVM-ERCC5, ERCC5, LOC126861834Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr13:103518680
GRCh38:
Chr13:102866330
LOC126861834, BIVM-ERCC5, ERCC5Q756H, Q1210HXeroderma pigmentosum, group GUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
68.
GRCh37:
Chr13:103518620
GRCh38:
Chr13:102866270
BIVM-ERCC5, ERCC5, LOC126861834L736F, L1190FXeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr13:103518252
GRCh38:
Chr13:102865902
BIVM-ERCC5, ERCC5, LOC126861834Xeroderma pigmentosum, group G, not providedConflicting interpretations of pathogenicity
(Sep 1, 2023)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr13:103518162
GRCh38:
Chr13:102865812
BIVM-ERCC5, ERCC5, LOC126861834not provided, Xeroderma pigmentosum, group GBenign
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr13:103515425
GRCh38:
Chr13:102863075
BIVM-ERCC5, ERCC5not provided, Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G
Benign/Likely benign
(Oct 6, 2020)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr13:103515416
GRCh38:
Chr13:102863066
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GConflicting interpretations of pathogenicity
(Dec 31, 2019)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr13:103515140
GRCh38:
Chr13:102862790
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Mar 1, 2023)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr13:103515062
GRCh38:
Chr13:102862712
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome
Benign/Likely benign
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr13:103514959
GRCh38:
Chr13:102862609
BIVM-ERCC5, ERCC5P487L, P941LCerebrooculofacioskeletal syndrome 3, not provided, Xeroderma pigmentosum, group G
Uncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr13:103514786
GRCh38:
Chr13:102862436
BIVM-ERCC5, ERCC5Hereditary cancer-predisposing syndrome, not provided, Xeroderma pigmentosum, group G
Conflicting interpretations of pathogenicity
(Sep 1, 2023)
criteria provided, conflicting interpretations
77.
GRCh37:
Chr13:103514731
GRCh38:
Chr13:102862381
BIVM-ERCC5, ERCC5T411M, T865MXeroderma pigmentosum, group G, Inborn genetic diseases, not provided
Conflicting interpretations of pathogenicity
(Nov 15, 2021)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr13:103514630
GRCh38:
Chr13:102862280
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GConflicting interpretations of pathogenicity
(Aug 1, 2023)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr13:103514609
GRCh38:
Chr13:102862259
ERCC5, BIVM-ERCC5Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome, not provided
Conflicting interpretations of pathogenicity
(Aug 1, 2023)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr13:103513923
GRCh38:
Chr13:102861573
BIVM-ERCC5, ERCC5I247V, I701VHereditary cancer-predisposing syndrome, not specified, Xeroderma pigmentosum, group G,
not provided
Uncertain significance
(Jul 21, 2023)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr13:103510766
GRCh38:
Chr13:102858416
BIVM-ERCC5, ERCC5E224Q, E678QXeroderma pigmentosum, group GUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr13:103510765
GRCh38:
Chr13:102858415
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr13:103510638
GRCh38:
Chr13:102858288
BIVM-ERCC5, ERCC5H181R, H635RXeroderma pigmentosum, group G, Inborn genetic diseases, not provided
Uncertain significance
(Jun 17, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr13:103506699
GRCh38:
Chr13:102854349
BIVM-ERCC5, ERCC5P148S, P602Snot provided, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G,
Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr13:103506686
GRCh38:
Chr13:102854336
ERCC5, BIVM-ERCC5Xeroderma pigmentosum, group G, not providedBenign
(Sep 21, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr13:103504506
GRCh38:
Chr13:102852156
BIVM-ERCC5, ERCC5R43W, R497WHereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group GUncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr13:103498545
GRCh38:
Chr13:102846195
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, not providedBenign
(Nov 11, 2018)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr13:103498543
GRCh38:
Chr13:102846193
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, not providedBenign
(Apr 3, 2019)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr13:103498491
GRCh38:
Chr13:102846141
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr13:103498461
GRCh38:
Chr13:102846111
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr13:103498417
GRCh38:
Chr13:102846067
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group G, not providedBenign/Likely benign
(Jun 1, 2023)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr13:103498376
GRCh38:
Chr13:102846026
BIVM-ERCC5, ERCC5Xeroderma pigmentosum, group GUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
93.
GRCh37:
Chr13:103498375
GRCh38:
Chr13:102846025
BIVM-ERCC5, ERCC5not provided, Xeroderma pigmentosum, group GBenign
(Nov 11, 2018)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr13:103498198
GRCh38:
Chr13:102845848
ERCC5, BIVM-ERCC5not provided, Xeroderma pigmentosum, group GBenign
(Nov 11, 2018)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr13:103514444
GRCh38:
Chr13:102862094
ERCC5, BIVM-ERCC5Hereditary cancer-predisposing syndrome, not specified, not provided,
Xeroderma pigmentosum, group G
Benign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr13:103524762
GRCh38:
Chr13:102872412
BIVM-ERCC5, ERCC5Cerebrooculofacioskeletal syndrome 3, not specified, Xeroderma pigmentosum, group G,
not provided
Benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr13:103504650
GRCh38:
Chr13:102852300
BIVM-ERCC5, ERCC5not specified, not provided, Xeroderma pigmentosum, group G
Benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr13:103514939
GRCh38:
Chr13:102862589
BIVM-ERCC5, ERCC5not specified, not provided, Xeroderma pigmentosum, group G
Benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr13:103527930
GRCh38:
Chr13:102875580
BIVM-ERCC5, ERCC5R1080*, G1080*, G1534*not specified, Xeroderma pigmentosum, group GConflicting interpretations of pathogenicity
(Jul 7, 2022)
criteria provided, conflicting interpretations
100.
GRCh37:
Chr13:103515288
GRCh38:
Chr13:102862938
BIVM-ERCC5, ERCC5V597L, V1051LCerebrooculofacioskeletal syndrome 3, Hereditary cancer-predisposing syndrome, not provided,
Xeroderma pigmentosum, group G
Conflicting interpretations of pathogenicity
(Oct 1, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination